Anti-Phosphotyrosine antibody [EPR16871]
- RabMAb
- Recombinant
- What is this?
Be the first to review this product! Submit a review
|
(21 Publications)
Anti-Phosphotyrosine antibody [EPR16871] (ab179530) is a rabbit monoclonal antibody detecting Phosphotyrosine in Western Blot, Flow Cytometry (Intra), Flow Cytometry, IP, ICC/IF, ELISA, Dot Blot.
- Biophysical QC for unrivalled batch-batch consistency
- Over 10 publications
View Alternative Names
L-Phosphotyrosine, L-Tyrosine-O-phosphate, O-Phospho-L-tyrosine, O-Phosphotyrosine, Phospho-L-tyrosine, Phosphonotyrosine
- Flow Cyt (Intra)
Supplier Data
Flow Cytometry (Intracellular) - Anti-Phosphotyrosine antibody [EPR16871] (AB179530)
Intracellular flow cytometric analysis of 2% paraformaldehyde-fixed Pervanadate (50mM, 30min.) treated (orange)/untreated (red)A431 (Human epidermoid carcinoma) cells labeling Phosphotyrosine with ab179530 at 1/160 dilutioncompared with a rabbit monoclonal IgG control (black) and an unlabelled control (cells without incubation with primary antibody and secondary antibody; blue). Goat anti rabbit IgG (FITC) at 1/150 dilution was used as the secondary antibody.
- ICC/IF
Supplier Data
Immunocytochemistry/ Immunofluorescence - Anti-Phosphotyrosine antibody [EPR16871] (AB179530)
Immunofluorescent analysis of 4% paraformaldehyde-fixed, 0.1% Triton X-100 permeabilized C2C12 (Mouse myoblast cell line) cells labeling Phosphotyrosine with ab179530 at 1/100 dilution, followed by Goat anti-rabbit IgG (Alexa Fluor® 488) (ab150077) secondary antibody at 1/400 dilution (green). Cytoplasm staining on C2C12 cells is observed. The expression increased after treatment with H2O2 (2mM) for 10 minutes. The nuclear counterstain is DAPI (blue). Tubulin is detected with ab7291 (anti-Tubulin mouse mAb) at 1/500 dilution and ab150120 (AlexaFluor®594 Goat anti-Mouse secondary) at 1/500 dilution (red).
The negative controls are as follows : -
-ve control 1 : - ab179530 at 1/100 dilution followed by ab150120 (AlexaFluor®594 Goat anti-Mouse secondary) at 1/500 dilution.
-ve control 2 : - ab7291 (anti-Tubulin mouse mAb) at 1/500 dilution followed by ab150077 (Alexa Fluor®488 Goat Anti-Rabbit IgG H&L) at 1/400 dilution.
- WB
Supplier Data
Western blot - Anti-Phosphotyrosine antibody [EPR16871] (AB179530)
Multiple bands represent phosph-tyrosine containing proteins detected by ab179530.
Blocking/Dilution buffer : 5% NFDM/TBST.
All lanes:
Western blot - Anti-Phosphotyrosine antibody [EPR16871] (ab179530) at 1/10000 dilution
Lane 1:
A431 (Human epidermoid carcinoma) whole cell lysates treated with 50mM pervanadate for 30 minutes at 10 µg
Lane 2:
Untreated A431 whole cell lysates at 10 µg
Secondary
All lanes:
Goat Anti-Rabbit IgG, (H+L),Peroxidase conjugated at 1/1000 dilution
false
- WB
Supplier Data
Western blot - Anti-Phosphotyrosine antibody [EPR16871] (AB179530)
Multiple bands represent phosph-tyrosine containing proteins detected by ab179530
All lanes:
Western blot - Anti-Phosphotyrosine antibody [EPR16871] (ab179530) at 1/1000 dilution
Lane 1:
Jurkat (Human T cell leukemia cells from peripheral blood) whole cell lysates treated with 1mM pervanadate for 20minutes at 10 µg
Lane 2:
Untreated Jurkat whole cell lysates at 10 µg
Secondary
All lanes:
Goat Anti-Rabbit IgG (H+L) Peroxidase conjugated at 1/1000 dilution
false
- IP
Supplier Data
Immunoprecipitation - Anti-Phosphotyrosine antibody [EPR16871] (AB179530)
Phosphotyrosine was immunoprecipitated from 1mg of A431 (Human epidermoid carcinoma) whole cell extract treated with 1mM pervanadate for 30 minutes with ab179530 at 1/100 dilution. Western blot was performed from the immunoprecipitate using ab179530 at 1/1000 dilution. Anti-Rabbit IgG (HRP), specific to the non-reduced form of IgG, was used as secondary antibody at 1/1500 dilution. Lane 1 : A431 treated with 1mM pervanadate for 30 minutes whole cell extract. Lane 2 : PBS instead of A431 whole cell extract.
Blocking and dilution buffer and concentration : 5% NFDM/TBST.
Multiple bands represent phosph-tyrosine containing proteins precipitated and detected by ab179530.
All lanes:
Immunoprecipitation - Anti-Phosphotyrosine antibody [EPR16871] (ab179530)
false
- ELISA
Lab
ELISA - Anti-Phosphotyrosine antibody [EPR16871] (AB179530)
Serially diluted ab179530 was bound to immobilised phospho- or control peptides (STAT1 (phospho S727), STAT1 control, STAT5 (phospho T694), STAT5 control); 1 microgram per mL).
The antibody was detected by Goat anti-Rabbit HRPO and signal was developed by TMB substrate.
- ELISA
Supplier Data
ELISA - Anti-Phosphotyrosine antibody [EPR16871] (AB179530)
ELISA analysis of various antigens (1 μg/ml) using ab179530 at 1/6400 dilution followed by Alkaline Phosphatase-conjugated Goat Anti-Rabbit IgG (H+L) at 1/2500 dilution.
S/N = signal-to-noise ratio of phospho- versus nonphospho-peptides.
- WB
Supplier Data
Western blot - Anti-Phosphotyrosine antibody [EPR16871] (AB179530)
Blocking and diluting buffer and concentration : 5% NFDM/TBST The identity of the bands around 50 kDa are unknown. In Western blot, Anti-GAPDH antibody [EPR16891] - Loading Control (ab181602) staining at 1/200000 dilution. In Western blot, Anti-phosphotyrosine antibody [EPR16871] (ab179530) staining at 1/1000 dilution.
All lanes:
Western blot - Anti-3-Nitrotyrosine antibody [EPR27217-88] (<a href='/en-us/products/primary-antibodies/3-nitrotyrosine-antibody-epr27217-88-ab314438'>ab314438</a>) at 1/1000 dilution
Lanes 1 and 7:
Untreated HeLa (human cervix adenocarcinoma epithelial cell) whole cell lysate at 20 µg
Lane 2:
HeLa treated with 3 mM peroxynitrite for 30 minutes whole cell lysate at 20 µg
Lane 3:
Untreated NIH/3T3 (mouse embryonic fibroblast) whole cell lysate at 20 µg
Lane 4:
NIH/3T3 treated with 3 mM peroxynitrite for 30 minutes whole cell lysate at 20 µg
Lane 5:
Untreated PC-12 (rat adrenal gland pheochromocytoma cell) whole cell lysate at 20 µg
Lane 6:
PC-12 treated with 3 mM peroxynitrite for 30 minutes whole cell lysate at 20 µg
Lane 8:
HeLa treated with 1 mM pervanadate for 30 minutes whole cell lysate at 20 µg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/100000 dilution
Observed band size: 1-250 kDa
false
Exposure time: 37s
- WB
Supplier Data
Western blot - Anti-Phosphotyrosine antibody [EPR16871] (AB179530)
Multiple bands represent phosph-tyrosine containing proteins detected by ab179530.
Blocking/Dilution buffer : 5% NFDM/TBST.
All lanes:
Western blot - Anti-Phosphotyrosine antibody [EPR16871] (ab179530) at 1/1000 dilution
Lane 1:
NIH/3T3 (Mouse embyro fibroblast cells) whole cell lysates treated with 1mM pervanadate for 10 minutes at 10 µg
Lane 2:
Untreated NIH/3T3 whole cell lysates at 10 µg
Secondary
All lanes:
Goat Anti-Rabbit IgG, (H+L),Peroxidase conjugated at 1/1000 dilution
false
- WB
Supplier Data
Western blot - Anti-Phosphotyrosine antibody [EPR16871] (AB179530)
Multiple bands represent phosph-tyrosine containing proteins detected by ab179530.
Blocking/Dilution buffer : 5% NFDM/TBST.
All lanes:
Western blot - Anti-Phosphotyrosine antibody [EPR16871] (ab179530) at 1/1000 dilution
Lane 1:
L6 (Rat skeletal muscle cell line) whole cell lysates treated with 1mM pervanadate for 20 minutes at 10 µg
Lane 2:
Untreated L6 whole cell lysates at 10 µg
Secondary
All lanes:
Goat Anti-Rabbit IgG, (H+L),Peroxidase conjugated at 1/1000 dilution
false
- Dot
Lab
Dot Blot - Anti-Phosphotyrosine antibody [EPR16871] (AB179530)
Dot blot analysis of INSR/IGF-1R (pY1009) phospho peptide (lane 1) and INSR/IGF-1R non-phospho peptide (lane 2) labelling Phosphotyrosine with ab179530 at a dilution of 1/1000. A peroxidase-conjugated goat anti-rabbit IgG (H+L) was used as the secondary antibody (1/2500).
Blocking and dilution buffer : 5% NFDM/TBST.
Exposure time : 3 minutes.
Reactivity data
Product details
What is this antibody validated in?
Anti-Phosphotyrosine antibody [EPR16871] (ab179530) is a rabbit recombinant monoclonal antibody and is validated for use in Western Blot (WB), Flow Cytometry (Intra), Flow Cytometry (Flow Cyt), Immunoprecipitation (IP), Immunocytochemistry/immunofluorescence (ICC/IF), ELISA, Dot Blot. Trusted by the scientific community
Anti-Phosphotyrosine [EPR16871] (ab179530) was first used in a scientific publication in 2014 and has been cited over 10 times in peer-reviewed journals.
Trial sizes available!
Test your antibody or perform pre-screening before committing to a larger quantity. Sold in 10µl. Discover our selection of trial-size antibodies.
Other related products
We have a range of other formats of antibody clone [EPR16871] also available for your convenience: ab179530, Alexa Fluor® 488 - ab205479, Alexa Fluor® 647 - ab205480, Biotin - ab222255, Carrier free - ab240219
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage duration
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
Phosphorylated tyrosine residues modify the function and activity of proteins within cells. It is a critical component of signal transduction pathways and can alter protein functions when becoming part of large protein complexes. It often regulates receptor proteins and intracellular kinases modifying their ability to interact with other proteins like SH2 and PTB domain-containing proteins. Phosphotyrosine antibodies like anti-phosphotyrosine Ig2 are helpful research tools for detecting these modifications.
Pathways
The modification of tyrosine to phosphotyrosine participates significantly in pathways such as the MAPK/ERK pathway and the PI3K/AKT pathway. These pathways are important for various cellular processes including growth and survival. Proteins like EGFR and PDGFR regulate signaling cascades by phosphorylation of tyrosine residues and often interact with phosphotyrosine and phosphotyrosine antibodies importantly.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (21)
Recent publications for all applications. Explore the full list and refine your search
Frontiers in veterinary science 12:1543459 PubMed40151572
2025
Applications
Unspecified application
Species
Unspecified reactive species
Nature communications 14:6117 PubMed37777542
2023
Applications
Unspecified application
Species
Unspecified reactive species
The EMBO journal 42:e112675 PubMed37092319
2023
Applications
Unspecified application
Species
Unspecified reactive species
Nature communications 14:1185 PubMed36864027
2023
Applications
Unspecified application
Species
Unspecified reactive species
Plant communications 4:100559 PubMed36774537
2023
Applications
Unspecified application
Species
Unspecified reactive species
eLife 11: PubMed35686730
2022
Applications
Unspecified application
Species
Unspecified reactive species
Frontiers in genetics 12:764509 PubMed34956319
2021
Applications
Unspecified application
Species
Unspecified reactive species
Cells 10: PubMed34831356
2021
Applications
Unspecified application
Species
Unspecified reactive species
Cancer immunology, immunotherapy : CII 70:3261-3275 PubMed33837850
2021
Applications
Unspecified application
Species
Unspecified reactive species
Clinical and translational medicine 11:e337 PubMed33783993
2021
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com